medigraphic.com
SPANISH

Revista del Instituto Nacional de Enfermedades Respiratorias

A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

Ver actualización

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2009, Number 3

Next >>

Rev Inst Nal Enf Resp Mex 2009; 22 (3)

Few thoughts about the clinical trials in idiopathic pulmonary fibrosis

Selman M, Navarro MC
Full text How to cite this article

Language: Spanish
References: 13
Page: 151-153
PDF size: 46.99 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Selman M, Thannickal VJ, Pardo A, Zisman DA, Martínez FJ, Lynch JP 3rd. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs 2004;64:405-430.

  2. King TE Jr, Albera C, Bradford WZ, et ál. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomized, placebo-controlled trial. Lancet 2009;374: 222-228.

  3. King TE Jr, Behr J, Brown KK, et ál. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008;177:75-81.

  4. Raghu G, Brown KK, Costabel U, et ál. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 2008;178:948-955.

  5. Daniels CE, Lasky JA, Limper AH, Mieras K, Gabor E, Schroeder DR. Imatinib treatment for IPF: Randomized placebo controlled trial results. Am J Respir Crit Care Med. [Epub ahead of print]

  6. Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, et ál. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2009 Dec 8. [Epub ahead of print]

  7. Ortiz LA, Gambelli F, McBride C, et ál. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003;100:8407-8411.

  8. Serrano-Mollar A, Nacher M, Gay-Jordi G, Closa D, Xaubet A, Bulbena O. Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 2007;176:1261-1268.

  9. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113:243-252.

  10. Lin YM, Zhang A, Rippon HJ, Bismarck A, Bishop A. Tissue engineering of lung: the effect of extracellular matrix on the differentiation of embryonic stem cells to pneumocytes. Tissue Eng Part A. [Epub ahead of print]

  11. Cargnoni A, Gibelli L, Tosini A, et ál. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 2009;18:405-422.

  12. Selman M, Carrillo G, Estrada A, et ál. Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS One 2007;2: e482.

  13. Goldstein DB. Personalized medicine. Nature 2010;463:26-32.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Inst Nal Enf Resp Mex. 2009;22